NasdaqGS - Delayed Quote USD
QuidelOrtho Corporation (QDEL)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 5:06 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 0.32 | 1.04 | 1.73 | 2.93 |
| Low Estimate | 0.22 | 0.84 | 1.51 | 2.26 |
| High Estimate | 0.43 | 1.16 | 1.96 | 3.25 |
| Year Ago EPS | 0.9 | 1.17 | 4.13 | 1.73 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 642.1M | 722.49M | 2.71B | 2.73B |
| Low Estimate | 632.67M | 698.46M | 2.68B | 2.67B |
| High Estimate | 653.26M | 737.02M | 2.74B | 2.81B |
| Year Ago Sales | -- | 742.6M | 3B | 2.71B |
| Sales Growth (year/est) | -- | -2.70% | -9.50% | 0.80% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.6 | 2.05 | 0.39 | -0.23 |
| EPS Actual | 0.9 | 1.17 | 0.44 | -0.07 |
| Difference | 0.3 | -0.88 | 0.05 | 0.16 |
| Surprise % | 50.00% | -42.90% | 12.80% | 69.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.32 | 1.04 | 1.73 | 2.93 |
| 7 Days Ago | 0.32 | 1.04 | 1.73 | 2.93 |
| 30 Days Ago | 0.32 | 1.06 | 1.75 | 3.01 |
| 60 Days Ago | 0.31 | 1.07 | 1.75 | 3.17 |
| 90 Days Ago | 0.46 | 1.17 | 1.96 | 3.36 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | QDEL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -64.40% | -- | -- | 4.50% |
| Next Qtr. | -11.10% | -- | -- | 9.60% |
| Current Year | -58.10% | -- | -- | 2.10% |
| Next Year | 69.40% | -- | -- | 12.90% |
| Next 5 Years (per annum) | 7.20% | -- | -- | 11.76% |
| Past 5 Years (per annum) | -3.58% | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | RBC Capital: Outperform to Outperform | 8/16/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 8/1/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 5/9/2024 |
| Downgrade | UBS: Neutral to Sell | 3/4/2024 |
| Downgrade | Craig-Hallum: Buy to Hold | 2/14/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 2/14/2024 |
Related Tickers
TNDM Tandem Diabetes Care, Inc.
31.35
-1.29%
IART Integra LifeSciences Holdings Corporation
18.95
+0.37%
GMED Globus Medical, Inc.
73.17
-0.64%
NARI Inari Medical, Inc.
43.70
-0.59%
BIO Bio-Rad Laboratories, Inc.
320.23
-2.39%
SNN Smith & Nephew plc
28.37
-3.83%
MASI Masimo Corporation
139.33
-1.00%
BRKR Bruker Corporation
57.90
-0.84%
EW Edwards Lifesciences Corporation
69.38
-1.38%
PODD Insulet Corporation
233.63
-1.68%